Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

19 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Kaletra Tablets Articles

Highlights from International AIDS conference include updates on S/GSK 1349572, Merck & Co’s Isentress, Abbott’s Kaletra and a microbial gel

20 July 2010

Compulsory licensing for two AIDS drugs extended by Thailand health authority

16 June 2010

Ecuador’s authorization of generic HIV/AIDS drug applauded by US consumer watchdog, calling for others to follow

26 April 2010

Tentative FDA appro for Aurobindo's generic Kaletra

23 March 2009

Abbott Labs' 3rd-qtr 2007 net earnings flat

29 October 2007

Abbott's new Kaletra tablets approved by EC

10 July 2006

Abbott files sNDA for Kaletra tablets

9 May 2005

Showing 1-7 of 7 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Neovacs moving forward in rheumatoid arthritis, say analysts
  • Encouraging results with Sangamo's SB-728-T in HIV treatment
  • Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
  • Bristol-Myers' data on Yervoy and nivolumab causes a stir
  • Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
  • Neovacs moving forward in rheumatoid arthritis, say analysts

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS